"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,1,"Short-term resolution of symptoms (days 1 to 4 after randomisation)","NSAIDs versus antibiotics","SUBGROUP_AND_OVERALL","Bleidorn 2010",2010,0,0,0,0,21,36,0,0,17,33,0,0,21.910418,1.132353,0.735854,1.742498,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014762.pub2/full","10.1002/14651858.CD014762.pub2","1::overall","CD014762_pub2_data","significance_only",TRUE,TRUE,FALSE,-0.749081554463749,-0.155189243256213,-1.37468066857913,-0.123482440348365,-0.310573962082027,0.000195475569600895,TRUE,TRUE
1,1,"Short-term resolution of symptoms (days 1 to 4 after randomisation)","NSAIDs versus antibiotics","SUBGROUP_AND_OVERALL","Gagyor 2012",2012,0,0,0,0,91,234,0,0,129,229,0,0,32.930867,0.690353,0.566923,0.840657,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014762.pub2/full","10.1002/14651858.CD014762.pub2","1::overall","CD014762_pub2_data","significance_only",TRUE,TRUE,FALSE,-0.749081554463749,-0.155189243256213,-1.37468066857913,-0.123482440348365,-0.310573962082027,0.000195475569600895,TRUE,TRUE
1,1,"Short-term resolution of symptoms (days 1 to 4 after randomisation)","NSAIDs versus antibiotics","SUBGROUP_AND_OVERALL","Kronenberg 2017",2017,0,0,0,0,10,133,0,0,20,120,0,0,12.517843,0.451128,0.220058,0.924831,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014762.pub2/full","10.1002/14651858.CD014762.pub2","1::overall","CD014762_pub2_data","significance_only",TRUE,TRUE,FALSE,-0.749081554463749,-0.155189243256213,-1.37468066857913,-0.123482440348365,-0.310573962082027,0.000195475569600895,TRUE,TRUE
1,1,"Short-term resolution of symptoms (days 1 to 4 after randomisation)","NSAIDs versus antibiotics","SUBGROUP_AND_OVERALL","Vik 2018",2018,0,0,0,0,70,181,0,0,131,178,0,0,32.640872,0.525494,0.428751,0.644067,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014762.pub2/full","10.1002/14651858.CD014762.pub2","1::overall","CD014762_pub2_data","significance_only",TRUE,TRUE,FALSE,-0.749081554463749,-0.155189243256213,-1.37468066857913,-0.123482440348365,-0.310573962082027,0.000195475569600895,TRUE,TRUE
2,1,"Duration of symptoms [days]","NSAIDs versus antibiotics","SUBGROUP_AND_OVERALL","Bleidorn 2010",2010,0,0,4.3,6.7,0,36,3.4,3.92,0,33,0,0,2.282371,0.9,-1.664928,3.464928,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014762.pub2/full","10.1002/14651858.CD014762.pub2","1::overall","CD014762_pub2_data","significance_only",TRUE,TRUE,FALSE,-0.749081554463749,-0.155189243256213,-1.37468066857913,-0.123482440348365,-0.310573962082027,0.000195475569600895,TRUE,TRUE
2,1,"Duration of symptoms [days]","NSAIDs versus antibiotics","SUBGROUP_AND_OVERALL","Gagyor 2012",2012,0,0,5.6,2.2,0,241,4.6,2.2,0,243,0,0,97.717629,1,0.608004,1.391996,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014762.pub2/full","10.1002/14651858.CD014762.pub2","1::overall","CD014762_pub2_data","significance_only",TRUE,TRUE,FALSE,-0.749081554463749,-0.155189243256213,-1.37468066857913,-0.123482440348365,-0.310573962082027,0.000195475569600895,TRUE,TRUE
